The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells

被引:85
作者
Ulrix, W [1 ]
Swinnen, JV [1 ]
Heyns, W [1 ]
Verhoeven, G [1 ]
机构
[1] Catholic Univ Louvain, Fac Med, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
关键词
differential display; differentiation; prostate cancer; androgen;
D O I
10.1016/S0014-5793(99)00845-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A differential display technique was used to identify androgen-regulated genes in LNCaP prostatic adenocarcinoma cells. One of the genes markedly upregulated by androgens proved to be identical to differentiation-related gene 1 (Drg1; also described as RTP, Cap43 and rit42), a gene whose expression has recently been shown to be diminished in colon, breast and prostate tumors. We show that Drg1 is abundantly expressed in the (androgen-exposed) human prostate and that its expression is stimulated some 14-fold in androgen-treated LNCaP cells. The ligand specificity of the induction reflects the altered specificity of the mutated androgen receptor in LNCaP, In androgen receptor negative tumor Pines basal expression is slightly higher than in LNCaP but inducibility is absent. These data suggest that Drg1 is a novel marker of androgen-induced differentiation in the human prostate. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:23 / 26
页数:4
相关论文
共 27 条
[1]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[2]   CHARACTERIZATION OF AN EARLY GROWTH-RESPONSE GENE, WHICH ENCODES A ZINC-FINGER TRANSCRIPTION FACTOR, POTENTIALLY INVOLVED IN CELL-CYCLE REGULATION [J].
BLOK, LJ ;
GROSSMANN, ME ;
PERRY, JE ;
TINDALL, DJ .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (11) :1610-1620
[3]  
CARTER HB, 1990, PROSTATE, V16, P39
[4]   An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter [J].
Cleutjens, KBJM ;
vanderKorput, HAGM ;
vanEekelen, CCEM ;
vanRooij, HCJ ;
Faber, PW ;
Trapman, J .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (02) :148-161
[5]   ENDOCRINE THERAPY OF PROSTATE-CANCER - OPTIMAL FORM AND APPROPRIATE TIMING [J].
CRAWFORD, ED ;
DEANTONIO, EP ;
LABRIE, F ;
SCHRODER, FH ;
GELLER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1062-1066
[6]  
Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO
[7]  
2-H
[8]  
HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809
[9]  
KAIGHN ME, 1979, INVEST UROL, V17, P16
[10]   Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis - GRP78/BiP and novel genes [J].
Kokame, K ;
Kato, H ;
Miyata, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29659-29665